Plasticell has announced collaborations with over 45 leading universities and industry partners to progress its therapeutic projects, facilitate drug discovery, improve product manufacturing and develop new technologies in a variety of high value areas such as cell therapy, gene therapy, cancer immunotherapy and drug discovery.
Scroll below to explore a range of projects we have carried out with partners.
Plasticell and GSK have studied the role of drugs on platelet formation and also the regeneration of human tissues as part of a collaboration with our sister company Progenitor Therapeutics. For more information please see press release 1, news item, press release 2 and meeting poster.
Plasticell and JCR have developed expansion of mesenchymal stem cells used in cell therapy. For more information please see press release.
Plasticell and UCB have collaborated on compound library screening for stem cell differentiation. For more information please see press release.
Plasticell and Pierre Fabre have discovered plant extracts that stimulate human brown adipose tissue metabolism. For more information please see press release.
Plasticell and Merck Millipore have developed and marketed stem cell research reagents. For more information please see press release 1, press release 2 and meeting poster.
Plasticell and Sigma have developed stem cell reporter cell lines using zinc finger nucleases. For more information please see press release.
Plasticell and Hamilton have developed robotic solutions for stem cell culture. For more information please see press release.
Plasticell and Molecular Devices have developed methods to increase growth factor secretion by stem cells. For more information please see meeting poster.
Plasticell and the CGT Catapult have developed GMP-compliant expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.6m. For more information please see press release.
Plasticell is contracted by MoD to develop regenerative medicines for the treatment of injuries resulting from combat or terrorism. For more information please see press release.
Plasticell and Anthony Nolan are collaborating in clinical development of Plasticell’s ex vivo expanded cord blood-derived hematopoietic stem cell product. For more information please see press release.
Plasticell and A*STAR are collaborating to create genetically modified stem cell lines and products. For more information, please see press release.
Plasticell and NHSBT have developed expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.5m. For more information please see press release.
Plasticell and European Brain Council are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M
Plasticell and the SNBTS have collaborated to produce red blood cells from stem cells. We have won government grants to fund projects valued at £1.3m.
Plasticell and LGC have developed expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.5m. For more information please see press release.
Plasticell and NIBSC have developed platform technologies for stem cell culture and screening. We have won government grants to fund projects valued at £1.1m. For more information please see press release.
Plasticell and the University of Cambridge have collaborated to study novel biomaterials for stem cell expansion.
Plasticell and the University of Oxford have developed expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.6m and Plasticell has funded two industrial PhD student. For more information please see press release.
Plasticell and the University of Edinburgh identified a novel embryonic haematopoietic progenitor cell and have collaborated to produce red blood cells from stem cells. We have won government grants to fund projects valued at £1.3m. For more information please see science paper, press release.
Plasticell and Imperial College have developed therapies for bone fractures. We have won government grants to fund projects valued at £1.3m and Plasticell has funded one industrial PhD student to develop models of the myometrium to study disorders leading to pre-term birth. For more information please see press release.
Plasticell and Karolinska Institutet are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M
Plasticell and Ospedale San Raffaele are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M
Plasticell and UCL have developed platform technologies for stem cell culture and screening. We have won government grants to fund projects valued at £2.4m and Plasticell has funded three separate projects involving industrial PhD students. For more information please see press release 1 and press release 2.
Plasticell and Professor Adrian Thrasher (ICH) have collaborated to increase the number of mobilised peripheral blood (PB) HSCs that can be transfected with lentiviral gene therapy vectors, for the treatment of severe childhood illnesses such as Wiskott-Aldrich syndrome. We have won government grant to fund projects valued at £950,000. For more information please see press release 1.
Plasticell and Universitat de Barcelona are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M
.png){kind=logo}
Plasticell and Institute of Bioengineering of Catalonia are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M
Plasticell and Kings College have collaborated on the commercialisation of hESC lines and pre-clinical testing of Plasticell’s therapeutic products For more information please see press release 1, press release 2
Plasticell and Cardiff University are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M
Plasticell and QMUL have developed stem cell reporter lines and protocols for generation of hepatocytes. We have won government grants to fund projects valued at £100,000 and Plasticell has funded one industrial PhD student.
Plasticell and NTU are collaborating to create genetically modified stem cell lines and products. For more information, please see press release.
Plasticell and Technische Universität Dresden are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M
Plasticell and Universidad Autónoma de Madrid are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M
Plasticell and NUI Galway have collaborated to study cancer stem cells. Plasticell has funded one industrial PhD student in Galway. For more information please see press release.
Plasticell and the Babraham Institute have collaborated to develop methods of stem cell culture.
Plasticell and the University of Strasbourg have developed protein and chemical cocktails for adult and embryonic stem cell differentiation. Plasticell has funded one industrial PhD student in Strasbourg.
Plasticell and Cell Guidance Systems have developed expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.6m. For more information please see press release.
Plasticell has collaborated with Progenitor Therapeutics to discover small molecule drugs that regenerate tissues of the human body. For more information please see press release 1, press release 2, press release 3, press release 4, meeting poster 1, meeting poster 2 and meeting poster 3.
Plasticell and Noveome (formerly Stemnion) have developed protocols for differentiation of amniotic fluid stem cells. For more information please see press release.
Plasticell and Sphere Fluidics have developed high efficiency gene transduction for gene therapy. For more information please see press release.
Plasticell and CellSpring have developed 3D models for high throughput cell-based screening. For more information please see press release.
Plasticell and organovo have developed 3D bioprinted bone tissues. For more information please see science paper.
Plasticell and Poietis are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M
Plasticell and Cairn Research are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M
Plasticell and GSK have studied the role of drugs on platelet formation and also the regeneration of human tissues as part of a collaboration with our sister company Progenitor Therapeutics.For more information please see press release 1, news item, press release 2 and meeting poster.
Plasticell and JCR have developed expansion of mesenchymal stem cells used in cell therapy.For more information please see press release.
Plasticell and UCB have collaborated on compound library screening for stem cell differentiation.For more information please see press release.
Plasticell and Pierre Fabre have discovered plant extracts that stimulate human brown adipose tissue metabolism.For more information please see press release.
Plasticell and Merck Millipore have developed and marketed stem cell research reagents.For more information please see press release 1, press release 2 and meeting poster.
Plasticell and Sigma have developed stem cell reporter cell lines using zinc finger nucleases.For more information please see press release.
Plasticell and Hamilton have developed robotic solutions for stem cell culture.For more information please see press release.
Plasticell and Molecular Devices have developed methods to increase growth factor secretion by stem cells.For more information please see meeting poster.
Plasticell and the CGT Catapult have developed GMP-compliant expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.6m.For more information please see press release.
Plasticell is contracted by MoD to develop regenerative medicines for the treatment of injuries resulting from combat or terrorism.
For more information please see press release.
Plasticell and Anthony Nolan are collaborating in clinical development of Plasticell’s ex vivo expanded cord blood-derived hematopoietic stem cell product.
For more information please see press release.
Plasticell and A*STAR are collaborating to create genetically modified stem cell lines and products.
For more information, please see press release.
Plasticell and NHSBT have developed expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.5m.
For more information please see press release.
Plasticell and European Brain Council are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M.
Plasticell and the SNBTS have collaborated to produce red blood cells from stem cells. We have won government grants to fund projects valued at £1.3m.
Plasticell and LGC have developed expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.5m.
For more information please see press release.
Plasticell and NIBSC have developed platform technologies for stem cell culture and screening. We have won government grants to fund projects valued at £1.1m.For more information please see press release.
Plasticell and the University of Cambridge have collaborated to study novel biomaterials for stem cell expansion.
Plasticell and the University of Oxford have developed expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.6m and Plasticell has funded two industrial PhD student.
For more information please see press release.
Plasticell and the University of Edinburgh identified a novel embryonic haematopoietic progenitor cell and have collaborated to produce red blood cells from stem cells. We have won government grants to fund projects valued at £1.3m.
For more information please see science paper, press release.
Plasticell and Imperial College have developed therapies for bone fractures. We have won government grants to fund projects valued at £1.3m and Plasticell has funded one industrial PhD student to develop models of the myometrium to study disorders leading to pre-term birth.
For more information please see press release.
Plasticell and Karolinska Institutet are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M.
Plasticell and Ospedale San Raffaele are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M.
Plasticell and UCL have developed platform technologies for stem cell culture and screening. We have won government grants to fund projects valued at £2.4m and Plasticell has funded three separate projects involving industrial PhD students.
For more information please see press release 1 and press release 2.
Plasticell and Professor Adrian Thrasher (ICH) have collaborated to increase the number of mobilised peripheral blood (PB) HSCs that can be transfected with lentiviral gene therapy vectors, for the treatment of severe childhood illnesses such as Wiskott-Aldrich syndrome. We have won government grant to fund projects valued at £950,000.
For more information please see press release 1.
Plasticell and Universitat de Barcelona are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M.
.png){kind=logo}
Plasticell and Institute of Bioengineering of Catalonia are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M.
Plasticell and Kings College have collaborated on the commercialisation of hESC lines and pre-clinical testing of Plasticell’s therapeutic productsFor more information please see press release 1, press release 2.
Plasticell and Cardiff University are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M.
Plasticell and QMUL have developed stem cell reporter lines and protocols for generation of hepatocytes. We have won government grants to fund projects valued at £100,000 and Plasticell has funded one industrial PhD student.
Plasticell and NTU are collaborating to create genetically modified stem cell lines and products.
For more information, please see press release.
Plasticell and Technische Universität Dresden are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M.
Plasticell and Universidad Autónoma de Madrid are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M.
Plasticell and NUI Galway have collaborated to study cancer stem cells. Plasticell has funded one industrial PhD student in Galway.
For more information please see press release.
Plasticell and the Babraham Institute have collaborated to develop methods of stem cell culture.
Plasticell and the University of Strasbourg have developed protein and chemical cocktails for adult and embryonic stem cell differentiation. Plasticell has funded one industrial PhD student in Strasbourg.
Plasticell and Cell Guidance Systems have developed expansion technologies for hematopoietic stem cells. We have won government grants to fund projects valued at £1.6m.
For more information please see press release.
Plasticell has collaborated with Progenitor Therapeutics to discover small molecule drugs that regenerate tissues of the human body.For more information please see press release 1, press release 2, press release 3, press release 4, meeting poster 1, meeting poster 2 and meeting poster 3.
Plasticell and Noveome (formerly Stemnion) have developed protocols for differentiation of amniotic fluid stem cells.For more information please see press release.
Plasticell and Sphere Fluidics have developed high efficiency gene transduction for gene therapy.
For more information please see press release.
Plasticell and CellSpring have developed 3D models for high throughput cell-based screening.
For more information please see press release.
Plasticell and organovo have developed 3D bioprinted bone tissues.
For more information please see science paper.
Plasticell and Poietis are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M.
Plasticell and Cairn Research are collaborating to develop advanced stem cell technologies for neurology, with particular focus on Huntington’s disease. This collaboration is funded by an EU grant of €3.70M.
We are committed to offering a range of services that are tailored to meet the unique needs of our clients and to deliver exceptional patient care.
Chemical Research
Advanced Microscopy
Anatomical Pathology
Advanced Technology and Equipment
We invest in state-of-the-art technology and cutting-edge laboratory equipment to ensure accurate and reliable test results.
Highly Skilled and Knowledgeable Staff
Our team consists of skilled laboratory professionals, including experienced technicians, scientists, and pathologists.
Accurate and Timely Results
We understand the importance of timely and accurate results in healthcare decision-making.
Trust in our collaborative approach and let us demonstrate why our team is the perfect partner for your success.
“Efficient, directed differentiation of stem cells to predetermined cell lineages remains a major challenge in the field of ESCs and IPSCs. We are pleased to partner with stem cell differentiation experts Plasticell to develop complementary products that address this rapidly growing market segment.”
Director of Marketing for Stem Cell Research Products, Sigma-Aldlricher
